The association between genetic polymorphisms in CYP19 and breast cancer risk in Korean women

Oncology Reports

Volumn 22, Issue 3, 2009, Pages 487-492

  Kim, Ji Young ^a   Lee, Chang Suk ^a   Kim, Hye Ok ^a   Jo, Yong Hwa ^a   Lee, Juhie ^b   Jung, Min Hyung ^b   Baik, Hyung Hwan ^a   Choe, Wonchae ^a   Kang, Insug ^a   Yoon, Kung Sik ^a  

^a Sungkyunkwan University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Breast cancer; CYP19; Insertion deletion polymorphism; Single nucleotide polymorphisms

Indexed keywords

AROMATASE; ESTROGEN RECEPTOR; GENOMIC DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INDEL MUTATION; KOREA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TANDEM REPEAT; ALLELE; BREAST TUMOR; ENZYMOLOGY; GENE DOSAGE; GENETICS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE;

ADULT; AGED; ALLELES; AROMATASE; BASE SEQUENCE; BREAST NEOPLASMS; FEMALE; GENE DOSAGE; HUMANS; KOREA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID;

EID: 70349327955     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000461     Document Type: Article

References (29)

1. McPherson K, Steel CM and Dixon JM: ABC of breast diseases. Breast cancer-epidemiology, risk factors and genetics. BMJ 321: 624-628, 2000.
2. Shin HR, Won YJ, Jung KW, Kong KJ, Yom SH, Lee JK, Noh HI, Pisani P, Park JG, Ahn YO, Lee SY, Lee CW, Woo ZH, Lee TY, Choi JS, Yoo CI and Bae JM: Nationwide cancer incidence in Korea, 1999-2001; first result using the National Cancer Incidence Database. Cancer Res Treat 37: 325-331, 2005.
3. Shin HR, Jung KW, Won YJ, Park JG and 139 KCCR-affiliated Hospitals: 2002 Annual report of the Korea Central Cancer Registry: Based on registered data from 139 hospitals. Cancer Res Treat 36: 103-114, 2004.
4. Hsieh CC, Trichopoulos D, Katsouyanni K and Yuasa S: Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 46: 796-800, 1990.
5. Kelsey JL: Breast cancer epidemiology: summary and future directions. Epidemiol Rev 15: 256-263, 1993.
6. Colditz GA: Epidemiology of breast cancer: finding from the nurses' health study. Cancer 15: S1480-S1489, 1993.
7. Henderson BD and Feigelson HS: Hormonal carcinogenesis. Carcinogenesis 21: 427-433, 2000.
8. Yager JD: Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Mongr 27: 67-73, 2000.
9. Nandi S, Guzman RC and Yang J: Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 92: 3650-3657, 1995.
10. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA and Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkes Prev 8: 843-854, 1999.
11. Dialyna IA, Arvanitis DA and Spandidos DA: Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1, and GSTT1 genes in breast cancer. Int J Mol Med 8: 79-87, 2001.
12. Kurosaki K, Saitoh H, Oota H, Watanabe Y, Kiuchi M and Ueda S: Combined polymorphism associated with a 3-bp deletion in the 5′-flanking region of a tetrameric short tandem repeat at the CYP19 locus. Nippon Hoigaku Zasshi 51: 191-195, 1997.
13. Mendelson CR, Means GD, Mehendroo MS, Corbin CJ, Steinkampf MP, Graham-Lorence S and Simson ER: Use of molecular probes to study regulation of aromatase cytochrome P450. Biol Report 42: 1-10, 1990.
14. Corbin CJ, Graham-Lorence S, McPhaul M, Manson JI, Mendelson CR and Simpson ER: Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P450 and its expression in nonsteroidogenic cells. Proc Natl Acad Sci USA 85: 8948-8952, 1998.
15. Polymeropoulos MH, Xiao H, Rath DS and Merril CR: Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 19: 195, 1991.
16. Hur SE, Lee S, Lee JY, Moon HS, Kim HL and Chung HW: Polymorphisms and haplotypes of the gene encoding the estrogen-metabolizing CYP19 gene in Korean women: no association with advanced-stage endometriosis. J Hum Genet 52: 703-711, 2007.
17. Haiman CA, Hankison SE, Spiegelman D, De Vivo I, Colditz GA, Willett WC, Speizer FE and Hunter DJ: A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer 87: 204-210, 2000.
18. Yasuo M, Kyoko I, Noriko I, Chiyomi E and Shinzaburo N: Breast cancer risk associated with polymorphism in CYP19 in Japanese women. Int J Cancer 89: 325-328, 2000.
19. Kristensen VN, Harada N, Yoshimura N, Haraldsen E, Lonning PE, Erikstein B, Daresen R, Kristensen T and Borresen-Dale AL: Genetic variant of CYP19(aromatase) and breast cancer risk. Oncogene 19: 1329-1333, 2000.
20. Lee KM, Abel J, Ko Y, Harth V, Park WY, Seo JS, Yoo KY, Choi JY, Shin A, Ahn SH, Noh DY, Harvenon A and Kang D: Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. Br J Cancer 10: 88: 675-678, 2003.
21. Healey CS, Dunning AM, Durocher F, Teare D, Pharoah PD, Luben RN, Easton DH and Ponder BA: Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis 21: 189-193, 2000.
22. Ribeiro FS, de Amorim LM, de Almeira Simão T, Mendonça GA, de Moura Gallo CV and Pinto LE: CYP19(TTTA)n polymorphism and breast cancer risk in Brazilian women. Toxicol Lett 164: 90-95, 2006.
23. Okobia MN, Bunker CH, Zmuda JM, Ezeome ER, Anyanwu SN, Uche EE, Ojukwu J, Kuller LH and Ferrell RE: Simple tandem repeat (TTTA)n polymorphism in CYP19 (aromatase) gene and breast cancer risk in Nigerian women. J Carcinog 5: 12, 2006.
24. Watanabe J, Harada N, Suemasu K, Higashi Y, Gotoh O and Kawajiri K: Arginine-cystein polymorphism at codon 264 of the human CYP19 gene does not affect aromatase activity. Phamacogenetics 7: 419-424, 1997.
25. Siegelmann DN and Buetow KH: Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk. Br J Cancer 79: 456-463, 1999.
26. Sasano H, Nagura H, Harada N, Goukon Y and Kimura M: Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25: 530-535, 1994.
27. Stemmermann GN: The pathology of breast cancer in Japanese women compared to other ethnic groups: a review. Breast Cancer Res Treat 18: S67-S72, 1991.
28. Miyoshi Y, Ando A, Hasegawa S, Ishitobi M, Yamamura J, Irahara N, Tanji Y, Taguchi T, Tamaki Y and Noguchi S: Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk. Eur J Cancer 39: 2531-2537, 2003.
29. Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T and Honjo H: Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 17: 897-902, 2002.